Download Citation
Article Source:
Oxaliplatin-Based Chemotherapy Is More Beneficial in KRAS Mutant than in KRAS Wild-Type Metastatic Colorectal Cancer Patients
Lin YL,
Liang YH,
Tsai JH,
Liau JY,
Liang JT,
et al.
(2014)
Oxaliplatin-Based Chemotherapy Is More Beneficial in KRAS Mutant than in KRAS Wild-Type Metastatic Colorectal Cancer Patients.
PLOS ONE 9(2): e86789.
https://doi.org/10.1371/journal.pone.0086789